Publications by authors named "Ryo Honma"

Claim this Profile
I
Immunomodulatory Macrophages Enable E-MNC Therapy for Radiation-Induced Salivary Gland Hypofunction.
Ryo Honma, Takashi I, Makoto Seki, Mayumi Iwatake, Takunori Ogaeri

Cells· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective-mononuclear cell (E-MNC) therapy alleviates salivary gland damage by suppressing lymphocyte infiltration in Sjögren-like disease.
Kayo Hasegawa, Jorge Luis Montenegro Raudales, Takashi I, Takako Yoshida, Ryo Honma

Front Bioeng Biotechnol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiapoptotic activity of methyl (3R,4E,6Z,15E)-3-hydroxyoctadecatrienoate in human cervical carcinoma HeLa cells.
Osamu Ohno, Keigo Sato, Ryo Honma, Ruri Chiba, Kenji Matsuno

Biosci Biotechnol Biochem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).
Yoshinori Sumita, Naoki Iwamoto, Makoto Seki, Takako Yoshida, Ryo Honma

Medicine (Baltimore)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory and vasculogenic conditioning of peripheral blood mononuclear cells reinforces their therapeutic potential for radiation-injured salivary glands.
Takashi I, Yoshinori Sumita, Takako Yoshida, Ryo Honma, Mayumi Iwatake

Stem Cell Res Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis